Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases-Reference-Cited by-同舟云学术

Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases

Published:2022-06-04 Issue:5 Volume:21 Page:3280
ISSN:2619-0125
Container-title:Cardiovascular Therapy and Prevention
language:
Short-container-title:Cardiovasc Ther Prev

Author:

Drapkina O. M.¹^ORCID,Fedin A. I.²,Dorofeeva O. A.³^ORCID,Medvedev V. E.⁴^ORCID,Kareva E. N.⁵^ORCID,Dzhioeva O. N.⁶^ORCID,Kuklin S. G.⁷,Solovieva Е. Yu.²^ORCID,Abdulganieva D. I.⁸^ORCID,Kim Z. F.⁸^ORCID,Grigorovich M. S.⁹^ORCID,Shaposhnik I. I.¹⁰^ORCID,Koryagina N. А.¹¹^ORCID,Seredenin S. B.³^ORCID

Affiliation:

1. National Medical Research Center for Therapy and Preventive Medicine

2. Pirogov Russian National Research Medical University

3. V.V. Zakusov Research Institute of Pharmacology

4. Medical Institute of the Peoples’ Friendship University of Russia

5. I.M. Sechenov First Moscow State Medical University

6. National Medical Research Center for Therapy and Preventive Medicine; Moscow State University of Medicine and Dentistry

7. Irkutsk State Medical Academy of Postgraduate Education, branch of Russian Medical Academy of Continuous Professional Education

8. Kazan State Medical University

9. State Medical University

10. South Ural State Medical University

11. E.A. Wagner Perm State Medical University

Abstract

It has now been established that psychosocial risk factors significantly worsen the course of cardiovascular diseases (CVDs) and reduce patients’ adherence to treatment. Patients with CVDs are characterized by a high prevalence of anxiety comorbidities, which can reach 50-60%. The presence of concomitant anxiety disorders seriously worsens the prognosis of CVDs. The results of studies showed that anxiety increases the risk of fatal myocardial infarction and sudden death by 1,9 times and 4,5 times, respectively. Therefore, the correction of psychosocial factors, in particular anxiety symptoms, should be an important component of the treatment of patients with CVDs. The conducted studies show that the use of fabomotizole in patients with CVD and concomitant anxiety disorders reduces the anxiety manifestations. In addition, a pronounced improvement of somatic status is recorded, which is important for improving the course and prognosis of CVDs. The accumulated experience of fabomotizole use makes it possible to recommend it for the treatment of patients with anxiety and CVDs.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;(6):7-122. (In Russ.) doi:10.15829/1560-4071-2018-6-7-122. EDN XSLTTF.

2. Somers JM, Goldner EM, Waraich P, Hsu L. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry. 2006;51(2):100-13. doi:10.1177/070674370605100206.

3. Davydov AT, Litvintsev SV, Butko DYu, et al. Experience in the diagnosis and treatment of anxiety disorder in the post-stroke period in patients who have suffered an ischemic stroke. Russian Medical Journal. 2008;16(5):266-9. (In Russ.)

4. Khaustova EA, Bezsheiko VG. Modern ideas about the diagnosis and therapy of anxiety disorders. International Neurological Journal. 2012;2(48):52-60. (In Russ.)

5. Krasnov VN, Dovzhenko TV, Bobrov AE. Anxiety and depressive disorders in patients of the primary medical network. Medical Bulletin. 2010;11(516):9-10. (In Russ.)

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myofascial and spondylogeniccardialgia.Difficulties of diagnosis (a literature review with a clinical case study);Manual Therapy;2024-08-29

2. Affective disorders accompanied by cognitive impairment in patients with a cardiological profile: prevalence, multimorbidity, medical and social risk factors;Russian Medicine;2024-08-25

3. Agomelatine: pharmacological profile, possible application, advantages;Neurology, Neuropsychiatry, Psychosomatics;2024-08-22

4. Analysis of the characteristic features of psychosocial adaptation of patients with coronary heart disease to chronic heart failure;Kazan medical journal;2024-06-03

5. Mental health disorders in workers;Medical Herald of the South of Russia;2023-06-28